Peri-procedural myocardial infarction and troponism: A quick journey through the land of confusion

Heart

Volumn 98, Issue 19, 2012, Pages 1400-1401

  Valgimigli, Marco ^a   Leonardi, Sergio ^b  

^a UNIVERSITY OF FERRARA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; CREATINE KINASE MB; TROPONIN;

ACUTE CORONARY SYNDROME; ANGIOGRAPHY; CARDIOVASCULAR MORTALITY; CORONARY ARTERY DISEASE; DIAGNOSTIC IMAGING; EDITORIAL; ELECTROCARDIOGRAM; HEART CATHETERIZATION; HEART INFARCTION; HEART MUSCLE INJURY; HEART MUSCLE NECROSIS; HUMAN; MORBIDITY; PERCUTANEOUS CORONARY INTERVENTION; PERI PROCEDURAL HEART INFARCTION; PRIORITY JOURNAL; PROGNOSIS; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STANDARD; WORLD HEALTH ORGANIZATION;

ANGIOPLASTY, BALLOON, CORONARY; CORONARY ARTERY DISEASE; CREATINE KINASE, MB FORM; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; TROPONIN T;

EID: 84866138995     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2012-302612     Document Type: Editorial

References (9)

1. Damman P, Wallentin L, Fox KA, et al. Long-term cardiovascular mortality after procedure-related or spontaneous myocardial infarction in patients with non-ST-segment elevation acute coronary syndrome: a collaborative analysis of individual patient data from the FRISC II, ICTUS, and RITA-3 trials (FIR). Circulation 2012;125:568-76.
2. Bonaca MP, Wiviott SD, Braunwald E, et al. American College of Cardiology/American heart Association/European Society of Cardiology/World heart Federation universal definition of myocardial infarction classification system and the risk of cardiovascular death: observations from the TRITON-TIMI 38 trial (Trial to Assess Improvement in Therapeutic outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis in myocardial infarction 38). Circulation 2012;125:577-83.
3. Vranckx P, Farooq V, Garg S, et al. Different cardiac biomarkers to detect peri-procedural myocardial infarction in contemporary coronary stent trials: impact on outcome reporting. Heart 2012;98:1424-30.
4. Thygesen K, Alpert JS, White HD. Universal definition of myocardial infarction. J Am Coll Cardiol 2007;50:2173-95.
5. Vranckx P, Cutlip DE, Mehran R, et al. Myocardial infarction adjudication in contemporary all-comer stent trials: balancing sensitivity and specificity. Addendum to the historical MI definitions used in stent studies. EuroIntervention 2010;5:871-4.
6. Novack V, Pencina M, Cohen DJ, et al. Troponin criteria for myocardial infarction after percutaneous coronary intervention. Arch Intern Med 2012;172:502-8.
7. Tricoci P, Leonardi S, White JA, et al . Re-elevation of troponin following percutaneous coronary intervention significantly Predicts 1-Year mortality in patients with high-risk Non-ST-segment elevation acute coronary Syndromes. Circulation 2011;124:A9150.
8. Leonardi S, Koehler ML, Truffa A, et al. A novel approach to define type 4a myocardial infarction in acute coronary syndrome patients undergoing early invasive management: insights from the Champion platform trial. Circulation 2011;124:A10045.
9. Leonardi S, Mahaffey KW, White HD, et al. Rationale and design of the cangrelor versus standard therapy to achieve optimal management of platelet inhibition phoenix trial. Am Heart J 2012;163:768-76.